Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab-Reference-Cited by-同舟云学术

Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab

Published:2020-05 Issue: Volume:125 Page:109861
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Pang Juntao,Xing Huaixin,Sun Yingui,Feng Shuo,Wang Suzhen

Funder

Shandong Academy of Medical Sciences Science and Technology Planning Project

Shandong medical and health science and technology development project

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference56 articles.

1. Lung Cancer group of chinese thoracic society; chinese alliance against lung cancer. Prevention and management of lung cancer in China;Hong;Cancer,2015

2. National cancer incidence and mortality in China, 2012;Chen;Chin. J. Cancer Res.,2016

3. Inoperable stage III non-small cell lung cancer: current treatment and role of vinorelbine;Provencio;J. Thorac. Dis.,2011

4. 2nd ESMO consensus conference on lung cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease;Besse;Ann. Oncol.,2014

5. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer;Sandler;Clin. Cancer Res.,2004

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm;Current Gene Therapy;2025-04

2. Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors;Journal of Controlled Release;2024-09

3. Advances in targeted nano-delivery of bevacizumab using nanoparticles: Current insights, innovations, and future perspectives;Journal of Drug Delivery Science and Technology;2024-09

4. Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation;Nanomedicine;2024-08-15

5. A review on lipid-polymer hybrid nanocarriers in cancer;Journal of Drug Delivery Science and Technology;2024-08